Engkang, Humaydi A.
HRN: 22-34-70 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2022
CEFUROXIME 1.5GM (VIAL)
12/19/2022
12/26/2022
IV
1.5g
Q8H
Fistula In Ano
Waiting Final Action
12/22/2022
CEFTRIAXONE 1G (VIAL)
12/22/2022
12/28/2022
IV
2g
OD
Syphilis Late Latent
Waiting Final Action